Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer
Thomas Jefferson University
Thomas Jefferson University
Memorial Sloan Kettering Cancer Center
Vigilant Biosciences, Inc.
Abramson Cancer Center at Penn Medicine
Alliance for Clinical Trials in Oncology